The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Astria Therapeutics, Inc.(NASDAQ:ATXS)


Catabasis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics in the United States. The company's lead product candidate is QLS-215, a monoclonal antibody inhibitor of plasma kallikrein that is in preclinical development fo...
Share this website to your friends
Astria Therapeutics . Op Cashflow Per Share ttm
Astria Therapeutics . Free Cashflow Per Share ttm
Astria Therapeutics . Cash Per Share ttm
Astria Therapeutics . (GAAP) P/E ratio ttm
Astria Therapeutics . P/B ratio ttm
No extra charts and metrics for this ticker.